Abcourt Closes US$ 8M Loan Facility to Start Sleeping Giant Mine GlobeNewswire July 03, 2025 NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ROUYN-NORANDA, Quebec, July 03, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation“) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that it […]
Berger Montague PCadvises investors that a securities class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) on behalf of purchasers of Organonsecurities betweenOctober 31, 2024 through April 30, 2025,inclusive (the “Class Period”). https://mma.prnewswire.com/media/232479/berger_montague.jpg Investor Deadline: Investors who purchased or acquired Organonsecurities during the Class Period may, no later
Following the publication of the report by United Nations Special Rapporteur Francesca Albanese, LaCaisse wishes to be clearand firmly rejects allegations that it facilitates or encourages international crimes through its investments. Allegations and facts must be corrected. For one, the majority of investments in the companies mentioned are not directly managed by LaCaisse. They are
NEW YORK, NY / ACCESS Newswire / July 3, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=155528&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
The American Academy of Physician Associates (AAPA) President and Chair of the Board, Todd Pickard, DMSc, PA-C, DFAAPA, FASCO, issued the following statement today in response to the passage of H.R.1, the “One Big Beautiful Bill Act.” https://mma.prnewswire.com/media/2724583/American_Academy_of_Physician_Associates_Logo.jpg “This bill will have grave consequences for healthcare in America. The passage of this legislation will undermine
The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific antibodies, and antibody-drug conjugates targeting GPRC5D are advancing rapidly through clinical pipelines. With limited cross-reactivity to normal tissues, GPRC5D presents a promising target, enhancing its commercial potential. DelveInsight's GPRC5D-directed Therapies Market
Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at theEmpire State Buildingin New York City and are investigating — Carisma Therapeutics Inc. (NASDAQ:CARM)related to
Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at theEmpire State Building in New York City and are investigating — DNOW Inc. (NYSE:DNOW)related to
Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at theEmpire State Buildingin New York City and are investigating — AlphaTime Acquisition Corp. (NASDAQ: ATMCR)
Home Bancorp, Inc. (Nasdaq: “HBCP”) (the “Company”), the parent company for Home Bank, N.A. (the “Bank”) (www.home24bank.com), plans to issue its earnings release for the quarter ended June 30, 2025, after the close of business on Monday, July 21, 2025. The earnings release and investor presentation will be posted to the Investor Relations page of